RecruitingNCT07254078

Registry of Patients With chrOnic thromboemboLic Pulmonary hypErTension

Registry of Patients With Chronic Thromboembolic Pulmonary Hypertension in Russia: Determinants of Long-term Outcomes in Real Clinical Practice

Sponsor

Irina E. Chazova

Enrollment

500 participants

Start Date

May 1, 2025

Study Type

OBSERVATIONAL

Conditions

Chronic Thromboembolic Pulmonary Hypertension

Summary

The goal of this observational study is to gather information on background, medical history, symptoms and physical condition, treatment options of people with chronic thromboembolic pulmonary hypertension in real clinical practice in Russia. The main question it aims to answer is: Which factors most influence the prognosis of participants?

Eligibility

Min Age: 18 Years

Plain Language Summary

Simplified for easier understanding

This study is building a registry — a large database — of patients with chronic thromboembolic pulmonary hypertension (CTEPH). CTEPH is a condition where old blood clots block the arteries in the lungs, causing high blood pressure in those arteries. Researchers want to track how patients with this condition do over time. **You may be eligible if...** - You have been diagnosed with CTEPH **You may NOT be eligible if...** - You have high blood pressure in your lungs caused by something other than old blood clots (a different type of pulmonary hypertension) Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREPulmonary endarterectomy

A surgical procedure to remove chronic blood clots from the pulmonary arteries

PROCEDUREBalloon pulmonary angioplasty

A minimally invasive procedure used to treat chronic thromboembolic pulmonary hypertension by dilatating narrowed pulmonary arteries and improving blood flow to the lungs

DRUGPulmonary hypertension-specific therapy

Medical treatment with any PH-specific drugs